"Leukemia L1210" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An experimental LYMPHOCYTIC LEUKEMIA of mice.
Descriptor ID |
D007939
|
MeSH Number(s) |
C04.557.337.372.594 C04.619.531.594
|
Concept/Terms |
Leukemia L1210- Leukemia L1210
- L1210, Leukemia
- Leukemia L 1210
- L 1210, Leukemia
|
Below are MeSH descriptors whose meaning is more general than "Leukemia L1210".
Below are MeSH descriptors whose meaning is more specific than "Leukemia L1210".
This graph shows the total number of publications written about "Leukemia L1210" by people in this website by year, and whether "Leukemia L1210" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Leukemia L1210" by people in Profiles.
-
Browman GP, Gorka C, Mehta C, Lazarus H, Abelson HT. Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate. Biochem Pharmacol. 1980 Aug 15; 29(16):2241-5.
-
Beardsley GP, Abelson HT. A thin-layer chromatographic method for separation of thymidine and deoxyuridine nucleotides. Anal Biochem. 1980 Jul 01; 105(2):311-8.
-
Beardsley GP, Rosowsky A, McCaffrey RP, Abelson HT. Methotrexate di-n-butyl ester effects on thymidine metabolism. Biochem Pharmacol. 1979 Oct 15; 28(20):3069-74.